Skip to main content
Top
Published in: Calcified Tissue International 2/2014

01-08-2014 | Original Research

Clinical Setting Influences Patterns of Interaction between Osteoporosis Patient and Physician

Author: Andrea Ildiko Gasparik

Published in: Calcified Tissue International | Issue 2/2014

Login to get access

Abstract

The importance of healthy behavior for bone health, as well as low adherence to anti-osteoporosis medication are well-described problems. Both, lifestyle habits and compliance with drug-therapy are influenced by the relationship between patients and physicians. We analyzed 152 consecutive doctor–patient interactions conducted in public and private practices specialized in the management of osteoporosis. We recorded the duration of the consultation and the relative length of: (a) Personal and medical history collection, (b) Physical examination, (c) Explanation of the diagnosis and treatment modalities, and (d) Administrative tasks. The overall length and the respective duration of the four phases of the consultation significantly differ in private versus public practices. In the private practice, doctors spend more time with the patient and dedicate a higher proportion of their time to history collection and explanation of diagnosis/treatment for osteoporosis. While we do not integrate data on medication adherence, we believe that since more time is dedicated to health education, patients consulting in the private sector have a greater probability to adopt a healthy lifestyle and better/ longer take anti-osteoporosis medications. Further investigations are needed to assess if the differences in patient and doctor behaviors in the public–private settings have a significant impact on therapeutic adherence and subsequently fracture reduction in patients receiving anti-osteoporosis treatment.
Literature
1.
go back to reference Hiligsmann M, Boonen A, Rabenda V, Reginster JY (2012) The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert Rev Pharmacoecon Outcomes Res 12:159–166PubMed Hiligsmann M, Boonen A, Rabenda V, Reginster JY (2012) The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis. Expert Rev Pharmacoecon Outcomes Res 12:159–166PubMed
2.
go back to reference Rabenda V, Reginster JY (2010) Overcoming problems with adherence to osteoporosis medications. Expert Rev Pharmacoecon Outcomes Res 10:677–689PubMed Rabenda V, Reginster JY (2010) Overcoming problems with adherence to osteoporosis medications. Expert Rev Pharmacoecon Outcomes Res 10:677–689PubMed
3.
go back to reference Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY (2010) Potential clinical and economic impact of non-adherence with osteoporosis medications. Calcif Tissue Int 86:202–210CrossRef Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY (2010) Potential clinical and economic impact of non-adherence with osteoporosis medications. Calcif Tissue Int 86:202–210CrossRef
4.
go back to reference Lekkerkerker F, Kanis JA, Alsayed N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kauman JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY (2007) Adherence to treatment of osteoporosis: a need for study. Osteoporos Int 18:1311–1317PubMedCrossRef Lekkerkerker F, Kanis JA, Alsayed N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kauman JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY (2007) Adherence to treatment of osteoporosis: a need for study. Osteoporos Int 18:1311–1317PubMedCrossRef
5.
go back to reference Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD (2007) Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 24:37–55PubMedCrossRef Papaioannou A, Kennedy CC, Dolovich L, Lau E, Adachi JD (2007) Patient adherence to osteoporosis medications: problems, consequences and management strategies. Drugs Aging 24:37–55PubMedCrossRef
6.
go back to reference Riva S, Monti M, Iannello P, Pravettoni G, Schulz PJ, Antonietti A (2014) A preliminary mixed-method investigation of trust and hidden signals in medical consultations. PLoS One 11:e90941CrossRef Riva S, Monti M, Iannello P, Pravettoni G, Schulz PJ, Antonietti A (2014) A preliminary mixed-method investigation of trust and hidden signals in medical consultations. PLoS One 11:e90941CrossRef
8.
go back to reference Marcinowicz L, Pawllkowska T, Konstantynowicz J, Chlabicz S (2014) New insight into the role of patients during medical appointments: a synthesis of three qualitative studies. Patient Mar. 25 [Epub ahead of print] Marcinowicz L, Pawllkowska T, Konstantynowicz J, Chlabicz S (2014) New insight into the role of patients during medical appointments: a synthesis of three qualitative studies. Patient Mar. 25 [Epub ahead of print]
9.
go back to reference Deveugele M, Derese A, van den Btink-Muinen A, Bensing J, De Maeseneer J (2002) Consultation length in general practice: cross sectional study in six European countries. BMJ 325:472PubMedCentralPubMedCrossRef Deveugele M, Derese A, van den Btink-Muinen A, Bensing J, De Maeseneer J (2002) Consultation length in general practice: cross sectional study in six European countries. BMJ 325:472PubMedCentralPubMedCrossRef
11.
go back to reference Jensen AL, Lomborg K, Wind G, Langdahl BL (2014) Effectiveness and characteristics of multifaceted osteoporosis group education-a systematic review. Osteoporos Int 25:1209–1224PubMedCrossRef Jensen AL, Lomborg K, Wind G, Langdahl BL (2014) Effectiveness and characteristics of multifaceted osteoporosis group education-a systematic review. Osteoporos Int 25:1209–1224PubMedCrossRef
12.
go back to reference Huss D, Deblals F, Blotman F, Cortet B, mercier F, Rousseaux C, Berger V, Gaudin AF, Cotte FE (2010) Compliance and treatment satisfaction of post-menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. BMC Womens Health 10:26 Huss D, Deblals F, Blotman F, Cortet B, mercier F, Rousseaux C, Berger V, Gaudin AF, Cotte FE (2010) Compliance and treatment satisfaction of post-menopausal women treated for osteoporosis. Compliance with osteoporosis treatment. BMC Womens Health 10:26
13.
go back to reference Nielsen DS, Langdahl BL, Sorensen OH, Sorensen HA, Brixen KT (2010) Persistence to medical treatment of osteoporosis in women at three different clinical settings—a historical cohort study. Scand J Public Health 38:502–507PubMedCrossRef Nielsen DS, Langdahl BL, Sorensen OH, Sorensen HA, Brixen KT (2010) Persistence to medical treatment of osteoporosis in women at three different clinical settings—a historical cohort study. Scand J Public Health 38:502–507PubMedCrossRef
14.
go back to reference Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vanneck C, Deswaef A, Verpooten GA, Reginster JY (2008) Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 19:811–818PubMedCrossRef Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vanneck C, Deswaef A, Verpooten GA, Reginster JY (2008) Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 19:811–818PubMedCrossRef
15.
go back to reference Cramer JA, Amonkar MM, Hebborn A, Altman R (2005) Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21:1453–1460PubMedCrossRef Cramer JA, Amonkar MM, Hebborn A, Altman R (2005) Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 21:1453–1460PubMedCrossRef
Metadata
Title
Clinical Setting Influences Patterns of Interaction between Osteoporosis Patient and Physician
Author
Andrea Ildiko Gasparik
Publication date
01-08-2014
Publisher
Springer US
Published in
Calcified Tissue International / Issue 2/2014
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-014-9869-0

Other articles of this Issue 2/2014

Calcified Tissue International 2/2014 Go to the issue